Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Chandran, Uma R ^a   Dhir, Rajiv ^a   Ma, Changqing ^a   Michalopoulos, George ^a   Becich, Michael ^a   Gilbertson, John ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; TRANSCRIPTION FACTOR; COMPLEMENTARY RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PROSTATE CANCER; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; UPREGULATION; DISEASE COURSE; DONOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; PROSTATE; PROSTATE TUMOR; REGRESSION ANALYSIS;

ADULT; AGED; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RNA, COMPLEMENTARY; TISSUE DONORS; UP-REGULATION;

EID: 26844467247     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-45     Document Type: Article

References (34)

1. Cancer facts and figures, 2003.
2. Sokoll LJ, Chan DW: Prostate-specific antigen. Urology Clinics North America 1997, 24:253-259.
3. Polasckik TJ, Oesterling JE, Partin AW: Prostate specific antigen. Its discovery and biochemical characteristics. Journal of Urology 1999, 162:293-306.
4. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB: Gene expression profiling of clear renal cell carcinoma: gene identification and prognostic classification. PNAS 2001, 98:9754-9759.
5. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415(6871):530-536.
6. Pomeroy S, Tamayo P, Gaasenbeek M, Sturla L, Mangelo M, McLaughlin ME, Kim JYH, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR: Prediction of central nervous system embryonal tumoru outcome based on gene expression. Nature 2002, 415:436-442.
7. Geisler S, JH, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botsten D, Lonning PE, Borresen-Dale A-L: Gene expression patterns of breast carcinomas distinguish tumor subcalsses with clinical implications. PNAS 2001, 98:10869-10874.
8. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S: Gene-experssion profiles predict survival of patients with lung adenocarcinoma. Nature Medicine 2002, 8(8):816-824.
9. Golub TR, Slomin DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov J P, Coller H LM, Downing JR,Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediciton by gene expression monitoring. Science 1999, 286:531-537.
10. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ, Meyerson M: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. PNAS 2001, 98:13790-13795.
11. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang, C-H, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda Massimo, Lander ES, Golub TR: Multiclass cancer diagnosis using tumor gene expression signatures. PNAS 2001, 98(26):15149-15154.
12. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, Michalopoulos G, Becich M, Luo JH: Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy. Journal of Clinical Oncology 2004, 2:2790-2799.
13. Sandberg AA: Chrosomal abnormalities and related events in prostate cancer. Human Pathology 1992, 23(4):368-380.
14. Waghray A, Schober M, Feroze F, Yao F, Virgin J, Chen YQ: Identification of differentially expressed genes by serial analysis of gene epxression in human prostate cancer. Cancer Research 2001, 61:4283-4286.
15. Bostwick DJ: Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer Reserach 1996, 78:330-336.
16. Bostwick DJ Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, Cheng L: Independent origin of multiple foci of prostatic intraepithelial neoplasia. Cancer 2000, 83(9):1995-2002.
17. Montironi R, Diaminiti L, Santinelli A, Magi GC, Scarpelli M, Giannulis I, Mangili F: Subtle changes in benign tissue adjacent to prostate neoplasia detected with a bayesian belief network. Journal of Pathology 1997, 182:442-449.
18. Bartels PH, Montironi R, Duval da Silva V, Hamilton PW: Tissue architecture analysis of prostate cancer and its precursors: an innovative approach to computerized histometry. European Urology 1999, 35:484-491.
19. Mairinger TG, Mikuz G, Gschwendtner: Nuclear chromatin texture analysis of nonmalignant tissue can detect adjacent prostatic adenocarcinoma. The Prostate 1999, 41:12-19.
20. Schadt E, Li C, Ellis B, Wong WH: Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. Journal of Cellular Biochemistry Supplement 2001, 37:120-125.
21. Tusher VG TR, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. PNAS 2001, 98(9):5116-5121.
22. Ashburner M, Ball C, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The gene ontology consortium. Nature Genetics 2000, 1:25-29.
23. Dhanasekaran SM, Barette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM: Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412:822-826.
24. Luo J, Duggan D, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM, Isaacs WB: Human Prostate Cancer and Benign Prostatic Hyperplasia: Molecular Dissection by Gene Expression Profiling. Cancer Reserach 2001, 61:4683-4688.
25. Luo JH, Yu YP, Cieply K, Lin F, Deflavia P, Dhir R, Finkelstein S, Michalopoulos G, Becich M: Gene expression analysis of prostate cancers. Molecular Carcinogenesis 2002, 33:25-35.
26. Chetcuti A, Margan S, Mann S, Russell P, Handelsman D, Rogers J, Dong: Identification of differentialy expressed genes in organ-confined prostate cancer by gene expression array. 2001, 47:132-140.
27. Prakash K, Pirozzi G, Elashoff M, Munger W, Waga I, Dhir R, Kakehi Y, Getzenberg RH: Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays. PNAS 2002, 99(11):7598-7603.
28. Singh D, Febbo PG, Ross, K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw, AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub T, Sellers WR: Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002, 1:203-209.
29. Dash A, Maine IP, Varambally S, Shen R, Chinnaiyan AM, Rubin MA: Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. American Journal of Pathology 2002, 161:1742-1748.
30. Rhodes DR, Barett TR, Rubin MA, Ghosh D, Chinnaiyan AM:Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Research 2002, 62:4427-4433.
31. MacAulay C, Lam S, Payne PW, LeRiche JC, Palcic B: Malignancy-associated changes in bronchial epithelial cells in biopsy specimens. Analytical quantitative cytology 1995, 17:55-61.
32. Montag AG, Bartels P, Dytch HE, Lerma-Puertas E, Michelassi F, Bibbo M.: Karyometric marker features in tissue adjacent to in situ cervical carcinoma. Analytical quantitative cytology 1989, 11:275-280.
33. Montag AG, Bartels PH, Dytch HE, Lerma-Puertas E, Michelassi F, Bibbo M: Karyometric features in nuclei near colonic adenocarcinoma. Statistical analysis. 1989 1991, 13:159-167.
34. Malins DC, Johnson PM, Barker EA, Polissar NL, Wheeler TM, Anderson KM: Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors. PNAS 2003, 100(9):5401-5406.